Human genetic engineering antibody TRD 109 as well as preparation method and application thereof

A genetically engineered antibody and antibody technology, applied in the direction of antibodies, anti-inflammatory agents, recombinant DNA technology, etc., can solve the problems of heavy economic burden for patients, high treatment costs, and less toxic and side effects, and improve the symptoms and structure of collagen-type arthritis Simple and stable effect
CN101696243BInactive Publication Date: 2012-05-16INST OF HYGIENE & ENVIRONMENTAL MEDICINE PLA ACAD OF MILITARY MEDICAL
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
INST OF HYGIENE & ENVIRONMENTAL MEDICINE PLA ACAD OF MILITARY MEDICAL
Publication Date
2012-05-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a human genetic engineering antibody TRD 109 which is screened by utilizing a molecular biological technology-ribosome display technology, aims to TNF-alpha and realizes high-efficiency expression of the antibody to a prokaryotic system. A biological characteristic research demonstrates that the TRD 109 is a human genetic engineering antibody which has high affinity, better stability, simple structure and easy construction and can specifically neutralize the TNF-alpha, inhibit the generation of multiple kinds of cell factors, block the generation and development of AR in the source and is a human anti TNF-alpha antibody which can reduce the infiltration of eosinophils in a mouse nasal mucous membrane and relieve mouse allergic rhinitis symptom; and a gene and a geneproduct of the human anti TNF-alpha antibody can be used for preparing a medicaments for diagnosing and treating diseases caused by overexpression of the TNF-alpha, such as preparing a medicament for treating diseases including allergic rhinitis and rheumatoid arthritis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of biotechnology, in particular to the human genetic engineering antibody TRD109 and its preparation method and application. Background technique

[0002] Allergic rhinitis (AR) is a nasal inflammatory disease triggered by allergens and mediated by IgE. It is the most common disease in otolaryngology and one of the most common chronic diseases in the world. The main symptoms are runny nose, nasal congestion, nasal itching and sneezing. With the rapid changes in modern human life style and ecological environment, the incidence of AR is increasing globally, and the incidence in cities is much higher than that in rural areas. Although AR is not a major disease, it has a great impact on people's work, study and life. Serious impact, has gradually become a global health problem. The principle of AR treatment is mainly to avoid exposure to allergens, drug control and immune regulation. At present, there is no specific tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More